BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1362 related articles for article (PubMed ID: 32228226)

  • 1. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.
    Xiong Y; Liu Y; Cao L; Wang D; Guo M; Jiang A; Guo D; Hu W; Yang J; Tang Z; Wu H; Lin Y; Zhang M; Zhang Q; Shi M; Liu Y; Zhou Y; Lan K; Chen Y
    Emerg Microbes Infect; 2020 Dec; 9(1):761-770. PubMed ID: 32228226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune and Metabolic Signatures of COVID-19 Revealed by Transcriptomics Data Reuse.
    Gardinassi LG; Souza COS; Sales-Campos H; Fonseca SG
    Front Immunol; 2020; 11():1636. PubMed ID: 32670298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic analysis of COVID‑19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.
    Cavalli E; Petralia MC; Basile MS; Bramanti A; Bramanti P; Nicoletti F; Spandidos DA; Shoenfeld Y; Fagone P
    Int J Mol Med; 2020 Oct; 46(4):1266-1273. PubMed ID: 32945352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pharmacological interactome between COVID-19 patient samples and human sensory neurons reveals potential drivers of neurogenic pulmonary dysfunction.
    Ray PR; Wangzhou A; Ghneim N; Yousuf MS; Paige C; Tavares-Ferreira D; Mwirigi JM; Shiers S; Sankaranarayanan I; McFarland AJ; Neerukonda SV; Davidson S; Dussor G; Burton MD; Price TJ
    Brain Behav Immun; 2020 Oct; 89():559-568. PubMed ID: 32497778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients.
    Zhou Z; Ren L; Zhang L; Zhong J; Xiao Y; Jia Z; Guo L; Yang J; Wang C; Jiang S; Yang D; Zhang G; Li H; Chen F; Xu Y; Chen M; Gao Z; Yang J; Dong J; Liu B; Zhang X; Wang W; He K; Jin Q; Li M; Wang J
    Cell Host Microbe; 2020 Jun; 27(6):883-890.e2. PubMed ID: 32407669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
    Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
    Elife; 2020 Jul; 9():. PubMed ID: 32633718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
    Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martínez-Colón GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
    Nat Med; 2020 Jul; 26(7):1070-1076. PubMed ID: 32514174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome.
    Pandolfi L; Fossali T; Frangipane V; Bozzini S; Morosini M; D'Amato M; Lettieri S; Urtis M; Di Toro A; Saracino L; Percivalle E; Tomaselli S; Cavagna L; Cova E; Mojoli F; Bergomi P; Ottolina D; Lilleri D; Corsico AG; Arbustini E; Colombo R; Meloni F
    BMC Pulm Med; 2020 Nov; 20(1):301. PubMed ID: 33198751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
    Blanco-Melo D; Nilsson-Payant BE; Liu WC; Uhl S; Hoagland D; Møller R; Jordan TX; Oishi K; Panis M; Sachs D; Wang TT; Schwartz RE; Lim JK; Albrecht RA; tenOever BR
    Cell; 2020 May; 181(5):1036-1045.e9. PubMed ID: 32416070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dynamic Immune Response Shapes COVID-19 Progression.
    Ong EZ; Chan YFZ; Leong WY; Lee NMY; Kalimuddin S; Haja Mohideen SM; Chan KS; Tan AT; Bertoletti A; Ooi EE; Low JGH
    Cell Host Microbe; 2020 Jun; 27(6):879-882.e2. PubMed ID: 32359396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.
    Di Giorgio S; Martignano F; Torcia MG; Mattiuz G; Conticello SG
    Sci Adv; 2020 Jun; 6(25):eabb5813. PubMed ID: 32596474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.
    Park JH; Lee HK
    Front Immunol; 2020; 11():2145. PubMed ID: 32983174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
    Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
    EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candesartan could ameliorate the COVID-19 cytokine storm.
    Elkahloun AG; Saavedra JM
    Biomed Pharmacother; 2020 Nov; 131():110653. PubMed ID: 32942152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine storm induced by SARS-CoV-2.
    Song P; Li W; Xie J; Hou Y; You C
    Clin Chim Acta; 2020 Oct; 509():280-287. PubMed ID: 32531256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
    Wang J; Jiang M; Chen X; Montaner LJ
    J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
    Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
    Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
    J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.